Table 4 Main outcomes
| Â | ICU stay, median days (IQR) | Hospital stay, median days (IQR) | Mortality, n(%) | |
|---|---|---|---|---|
All patients n = 130 | 9 (14 to 5.5) | 20 (31 to 15) | 12 (9.2%) | |
Influence of CVVH on outcome in whole group | CVVH n = 75 | 12 (11 to 5) | 20 (32 to 15) | 8 (10.7%) |
| Â | no CVVH n = 55 | 7 (16.5 to 6) | 19 (27 to 15) | 4 (7.3%) |
| Â | p value | NS | NS | NS |
Influence of IAH on outcome in whole group | IAH n = 89 | 10 (16 to 6) | 32 (16 to 6) | 11 (12.4%) |
| Â | Normal IAP n = 41 | 6 (9 to 4) | 16 (23.5 to 13) | 1 (2.4%) |
| Â | p value | NS | 0.05 | 0.044a |
Influence of CVVH on outcome in patients with IAH | CVVH N = 60 | 9 (16 to 6) | 32 (60 to 12) | 7 (11.7%) |
| Â | No CVVH N = 29 | 10 (16 to 7.5) | 24 (34 to 4) | 4 (13.8%) |
| Â | p value | NS | 0.05 | NS |